- Leadership
- Team
- Board of Directors
- Advisory Board
Our leadership team has a proven track record of operational and commercial success alongside deep technical expertise
Dr. Daniel Turner
Chief Scientific Officer
Dr. Daniel Turner
Chief Scientific Officer
Dan has over 20 years of senior leadership experience within the fields of genetics, molecular biology, and sequencing research. Previously, he held roles including Senior Vice President, Vice President and Senior Director of Applications at Oxford Nanopore Technologies. During his tenure at Oxford Nanopore, he established various strategic collaborations and led projects to demonstrate the range of applications of the company’s technology. Dan has also held the role of Head of Sequencing Technology Development at the Wellcome Trust Sanger Institute. He holds a degree in Biochemistry from the University of Oxford and completed an MSc and PhD in Genetics at the University of Manchester Institute of Science and Technology.
Dr. Stefan Schoenfelder
Chief Scientific Advisor
Dr. Stefan Schoenfelder
Chief Scientific Advisor
Stefan is a recognized expert in the area of 3D genome organization and function. Having led the development of Capture Hi-C while working in Prof. Fraser’s laboratory, Stefan is a group leader in the Epigenetics Program at the Babraham Institute. He co-founded Enhanced in 2020 and continues to serve as Chief Scientific Advisor.
Dr. Mohamood Adhil
Lead Data Scientist
Dr. Mohamood Adhil
Data Science Team Leader
Adhil has extensive experience in extracting meaningful information from large biological and clinical datasets. He has a Master’s degree in Life Sciences Informatics and completed his PhD under the supervision of Prof. Marco Foiani, studying DNA supercoil role in genome organization. Prior to joining Enhanced, Adhil was a product manager and data scientist at InterpretOmics, where he was responsible for the development of omics-based clinical software and knowledge bases tailored to enhance precision medicine.
Dr. Helen Bignell
Principal Scientist
Dr. Helen Bignell
Principal Scientist
Helen is highly experienced in technology development within the field of genomics, successfully taking innovative ideas to commercialized products. She holds a Master’s and a PhD in Molecular and Cell Biology. Previously Helen worked at Biomodal (formerly Cambridge Epigenetix) developing epigenetic tools to identify methylation in DNA. Prior to this Helen spent 10 years at Solexa/Illumina as a major contributor working on many aspects of the early NGS (Next Generation Sequencing) technology.
Dr. Laura Caller
Team Leader
Dr. Laura Caller
Senior Scientist
Laura is a molecular biologist with experience designing and executing wide-ranging CRISPR screens, and target validation. Before joining Enhanced Genomics Laura studied host-virus interactions using proteomic and whole-genome CRISPR screening at both University of Cambridge and The Francis Crick Institute, London. Laura gained her PhD in Pathology at University of Cambridge.
Dr. Kishen Chahwala
Business Development Manager
Dr. Kishen Chahwala
Business Development Manager
Kishen holds a PhD in Genetics from the University of Cambridge, where he investigated neurodegeneration in axons using various genetic tools. Previously, Kishen worked at Biomodal (formerly Cambridge Epigenetix) and helped to develop their automated sample processing pipeline. Kishen has also had the opportunity to work for Start Codon and was responsible for landscaping and upgrading their suite of investment pipeline tools. It was here that Kishen discovered his passion for business and the commercialization of science.
Dr. Lyubomira Chakalova
Principal Scientist
Dr. Lyubomira Chakalova
Senior Scientist
Lyubomira has over 20 years of experience in cutting-edge methodology development in molecular and cellular biology. Before joining Enhanced, Lyubomira worked in the Fraser group at Babraham for 10 years and previously led her own independent research group. At Enhanced Lyubomira is focused on maximising the value of the Company’s technology.
Felix Llanwarne
Scientist
Felix Llanwarne
Scientist
Felix, an immunologist by training, is deeply passionate about understanding the intricacies of the human immune system and our responses to diseases. Prior to joining Enhanced Genomics, Felix was completing his PhD research at the London School of Hygiene and Tropical Medicine. His doctoral work focused on investigating T and B cell responses in infectious diseases, with a particular emphasis on long-term immunity. During this period, Felix gained extensive expertise in human cellular and humoral immunological assays, ranging from multiparameter flow cytometry to Luminex and microarrays. His wealth of experience and unwavering interest in immunology make him a valuable asset to our team at Enhanced Genomics.
Dr. Lira Mamanova
Lead Scientist
Dr. Lira Mamanova
Lead Scientist
Lira is a highly experienced scientist with proven scientific, administrative and service experience with a strong interest in new technologies, and how to best apply them. Lira had previously worked at the Wellcome Sanger Institute for 14 years, developing and optimizing various Next Generation Sequencing (NGS)-based technologies, including a high-throughput Single-cell transcriptomics and genomics pipelines. Lira led a team in a fast-paced and innovative environment. Prior to this she has worked at Imperial College London. She holds a Master's degree and a PhD in Genetics from Moscow State University.
Catherine Maurice
Financial Controller
Catherine Maurice
Accountant
Catherine joined the team with over 20 years of accounting experience working with a range of companies, including in practice and running her own outsourced accounting support service. She qualified with the Association of Accounting Technicians in 2005.
Patrizia Messina
Laboratory and Site Manager
Patrizia Messina
Laboratory Manager
Patrizia has a Master's degree in Biological Science and a post degree specialization in Human Nutrition. Originally from Italy, she moved to Cambridge to join the MRC Epidemiology Unit, where she worked for 7 years. She has 20 years of experience, both in research and clinical laboratories, covering a wide range of methodologies but with a particular focus on establishing and validating large-scale human sample measurement pipelines with robotic assistance.
Sophie Miller
HR & Operations Assistant
Sophie Miller
Office Assistant
Sophie graduated from the University of York with a degree in Psychology in 2020 and initially started her career in mental health. Following this, Sophie worked as a detective where she honed essential skills in confidentiality, communication, and teamwork. Her ability to analyze complex situations and work collaboratively with others set her apart. Now, as a valued member of the Enhanced Genomics team, Sophie brings her unique blend of experiences to the forefront. Her dedication to excellence and adaptability make her an incredible member of the team.
Dr. Consuelo Perez
Scientist
Dr. Consuelo Perez
Scientist
Consuelo is a molecular and stem cell biologist with experience in in vitro cellular models, CRISPR-based genome engineering and multi-omic workflows. She is passionate about deciphering underlying disease mechanisms at a molecular and cellular level to uncover new therapeutic opportunities. Prior to joining Enhanced Genomics, Consuelo completed her PhD at the MRC Laboratory of Molecular Biology and University of Cambridge where she investigated the role of 3D DNA topological changes in regulatory chromatin dynamics during developmental cell-fate transitions.
Alex Scott-Simons
Head of Bioinformatics Engineering
Alex Scott-Simons
Head of Bioinformatics Engineering
After initially training in Chemistry, Alex held a range of hands-on and management positions across data science and data engineering. He has built commercially successful data science products from scratch and gained global experience at high-profile companies (including Facebook, Lazada, and WPP) in consumer and advertising technology before returning to science and joining Enhanced.
Dr. Carine Stapel
Principal Scientist
Dr. Carine Stapel
Principal Scientist
Carine is a Molecular Biologist with extensive experience in the development and application of novel technologies to study gene regulation. She completed her PhD in single molecule RNA imaging and a postdoc in single-cell multi-omics. Prior to joining Enhanced Genomics, Carine worked at Serna Bio where she set up the lab and managed several drug discovery projects.
Dr. Jenni Westoby
Lead Bioinformatics Engineer
Dr. Jenni Westoby
Lead Bioinformatics Engineer
Jenni is a bioinformatician who specializes in developing automated bioinformatics workflows. She holds a bioinformatics PhD in single-cell RNA-seq and alternative splicing from the University of Cambridge. Prior to joining Enhanced Genomics, Jenni worked at Inivata developing precision medicine bioinformatics pipelines, and at CS Genetics performing single-cell RNA-seq analyses and automating daily pipeline runs.
Our Board of Directors comprises industry leaders with deep expertise in biotech, life sciences, and venture capital, providing strategic guidance to drive our growth and innovation
Dr. Karolina Zapadka
Board Member
Dr. Karolina Zapadka
Board Observer
Karolina has nearly a decade of experience in building life sciences and healthcare companies within the Cambridge Cluster. She played a pivotal role in securing pre-seed and seed investment from a stellar syndicate of investors. In 2018 she co-founded and successfully delivered the first life sciences startup accelerator with a portfolio of 20 early-stage ventures in Cambridge. She started her career as a scientist at a leading biopharmaceutical company delivering a portfolio of products to clinics. Karolina completed a PhD in biophysics (diabetes & neurosciences) from the University of Cambridge and carried out a drug development postdoc work at MedImmune/AstraZeneca.
Elaine Eggington
Board Observer
Elaine Eggington
Board Observer
Elaine is Executive Director (Consulting) at IP Pragmatics, an established and respected specialist management consultancy that provides a range of intellectual property management and commercialization services. Following a career in biotech and the life science industry, Elaine has been successfully commercializing early stage technologies through venture capital investment and consultancy since 2000. She has worked with The Babraham Institute to support their Knowledge Exchange and Commercialization activities for several years, and helped to spin out Enhanced Genomics from their cutting edge research.
Dirk Reyn
Board Member
Dirk Reyn
Board Member
Dirk Reyn is a Pharmacist and MBA'er with International Marketing, Global Sales Management, Product Development, Crisis Management, Business Development and General Management/biotech CEO skills acquired in the international pharmaceutical industry over a period of more than 38 years in both big and small companies and in different continents. He was a key player in at least 6 major pharma licensing and M&A deals in his capacity as head of BD for Europe while working for JNJ. After his tenure in big pharma (Lilly and JNJ), he was start-up CEO and founder of different companies including Movetis (2006), a public (Euronext) biopharmaceutical spin-off company from Janssen Pharmaceutica that was acquired by Shire, Progress Pharma (2012) that worked on a GI asset (Lipid, Heidelberg) before it was acquired by Nestle, eTheRNA (2015), a mRNA technology spin-off from the Free University of Brussels, and Spectricity (2018), an Imec spin-off with the smallest spectrometer on the planet. He currently is one of the three Managing Partners of the Bioqube Factory Fund (2020), a specialized biotech investment Fund with 110 million under management. He is also President of Flanders.bio the organization of biotech companies in Flanders.
Dr. Joris Vanderlocht
Board Observer
Dr. Joris Vanderlocht
Board Member
Joris currently is the Chief Scientific Director at Bioqube. He joined Bioqube Ventures as an immunology expert in 2018. Joris has over 15 years of experience in academic research and is specialized in the fundamental and translational aspects of human immunology. He started his career as a postdoctoral fellow at the Maastricht University Medical Center developing cellular immunotherapy for cancer. Later he managed several diagnostic programs in the clinic, including kidney transplantation, autoimmunity, immune deficiencies and hematological malignancies. Joris currently leads venture creation efforts at Bioqube and provides hands-on support across the portfolio.
Our advisory board includes our scientific founders Prof. Peter Fraser and Dr. Stefan Schoenfelder
Prof. Peter Fraser
Co-Founder
Prof. Peter Fraser
Co-Founder
Peter is a world-leading expert in gene expression and chromosomal architecture and the inventor of the GenLink platform. During the scientific discovery and early concept of the business, Peter led the Nuclear Dynamics Program at the Babraham Institute in Cambridge, UK. Peter is Chair at Florida State University where he is Director of the Centre for Genomics and Personalized Medicine.
Dr. Stefan Schoenfelder
Co-Founder
Dr. Stefan Schoenfelder
Co-Founder
Stefan is a recognized expert in the area of 3D genome organization and function. Having led the development of Capture Hi-C while working in Prof. Fraser’s laboratory, Stefan is a group leader in the Epigenetics Program at the Babraham Institute. He co-founded Enhanced Genomics in 2020 and continues to serve as Chief Scientific Advisor.
Dr. Louise Jopling
Strategic Advisor
Dr. Louise Jopling
Strategic Advisor
Louise is an immunologist with extensive experience working across drug discovery, development and commercialization domains within academia (University of Edinburgh, Imperial College London), biotech (Celltech) and pharmaceutical (UCB & Janssen/Johnson & Johnson Innovation) organizations.
Louise leads the commercial team at Eastern AHSN to develop partnerships and support innovators refine their business models, value propositions and navigate the NHS to maximize population benefit and generate economic growth at a regional and national level.
Louise has a BSc (hons) in Zoology (Parasitology) from the University of Aberdeen, a PhD in Immunology from Imperial College London and conducted her postdoctoral training at Boston Children’s Hospital, Harvard Medical School.
Prof. Adrian Liston
Scientific Advisor
Prof. Adrian Liston
Scientific Advisor
Prof Adrian Liston is Professor of Pathology at the Department of Pathology, University of Cambridge, Honorary Group Leader at the Babraham Institute, Professorial Fellow and Director of Studies at St Catharine's College, and Editor-in-Chief of Immunology & Cell Biology. Liston runs a biomedical research laboratory together with Dr James Dooley, Principal Research Associate. The Liston-Dooley laboratory currently works on understanding the regulation of immune responses in the tissues, in particular the brain and lung. The laboratory has extensive experience in the fields of neuroimmunology, autoimmune genetics, diabetes, primary immunodeficiencies, systems immunology, the thymus and regulatory T cells. Prof Liston has been awarded fellowship to the Academy of Medical Sciences, the Francqui Chair, the Eppendorf Prize, a Wellcome Trust Investigator Award and three ERC grants, among other honours. Liston has published more than 200 scientific papers, with >16,000 citations and a h-index of 61.
Dr. Rab Prinjha
Scientific Advisor
Dr. Rab Prinjha
Scientific Advisor
Rab Prinjha is the former head of GSK’s Immunology Research Unit and elected fellow of the Academy of Medical Sciences.
He served on the OpenTargets, Altius and Milner Governance Boards and as a member of the Padlock and Sitryx Boards. He has an extensive record of successful leadership with multiple projects progressed from target discovery to beyond Ph2. He is passionate about collaborative science and has published extensively with papers in the areas of immunology, oncology, epigenetics and neuroscience. Rab joined GSK from academia, completing a post-doc in neuroscience at Guy’s Hospital and PhD in molecular cellular immunology at UCL.
Prof. Rahul Roychoudhuri
Scientific Advisor
Prof. Rahul Roychoudhuri
Scientific Advisor
Rahul Roychoudhuri is a Professor of Cancer Immunology and Immunotherapy at the University of Cambridge Department of Pathology, and Director of Studies in Pathology at St Catherine’s College. He is Director (non-clinical) of the CRUK Cambridge Centre Training Programme and co-leads the CRUK Cambridge Centre Fundamental Cancer Biology Programme.
Rahul studied Natural Sciences at the University of Cambridge and Clinical Medicine at King’s College London. Rahul undertook his Ph.D. in Gary Nabel’s laboratory at the US National Institutes of Health (NIH) and a postdoctoral fellowship at Nicholas Restifo’s laboratory at the US National Cancer Institute (NCI). His research has made fundamental contributions to our understanding of immune regulation, tumor immunosuppression, immunological memory and gene regulation.
